Statins for Secondary Stroke Prevention in Patients without Known Coronary Heart Disease: The Jury Is Still Out

Publisher： Karger

E-ISSN： 1421-9786|18|1|1-2

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.18, Iss.1, 2004-12, pp. : 1-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Risk and Benefit of Statins in Stroke Secondary Prevention

By  

Current Vascular Pharmacology, Vol. 11, Iss. 6, 2013-11 ,pp. : 812-816

Bentham Science Publishers

Access to resources Recommend Favorite

Update of antibiotic trials for secondary prevention of coronary heart disease

By Anderson JL   Muhlestein JB  

Future Cardiology, Vol. 1, Iss. 2, 2005-03 ,pp. : 225-234

Future Medicine

Access to resources Recommend Favorite

Alcohol, Stroke and Coronary Heart Disease

By  

Neuroepidemiology, Vol. 18, Iss. 6, 1999-10 ,pp. : 292-302

Karger

Access to resources Recommend Favorite

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study

By Satar N.   Gaw A.   Scherbakova O.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 26-26

Elsevier

Access to resources Recommend Favorite

Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study

By Athyros Vasilios G.   Mikhailidis Dimitri P.   Papageorgiou Athanasios A.   Bouloukos Vasilios I.   Pehlivanidis Anthimos N.   Symeonidis Athanasios N.   Kakafika Anna I.   Daskalopoulou Stella S.   Elisaf Moses  

Platelets, Vol. 16, Iss. 2, 2005-03 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite